NUWE
$1.08
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy.
Intraday
Recent News
Nuwellis, Inc. Q4 2025 Earnings Call Summary
Moby summary of Nuwellis, Inc.'s Q4 2025 earnings call
Nuwellis (NUWE) Q4 2025 Earnings Call Transcript
In addition to myself, with us today are John L. Erb, Nuwellis, Inc.'s Chairman of the Board and CEO, and our newly appointed CFO, Carissa Schultz. At 8:00 a.m. Eastern Time today, Nuwellis, Inc. released financial results for the fourth quarter and full year 2025.
BC-Most Active Stocks
Nu Holdings Ltd. 46,657,078 18.56
Nuwellis Inc (NUWE) Q3 2025 Earnings Call Highlights: Strong Sequential Growth Amid Revenue ...
Despite a year-over-year revenue decline, Nuwellis Inc (NUWE) showcases significant growth in consumables and US console sales, while advancing strategic initiatives for long-term success.
Nuwellis Inc (NUWE) Q2 2025 Earnings Call Highlights: Strategic Shifts Amid Revenue Challenges
Nuwellis Inc (NUWE) navigates operational hurdles with strategic transitions and growth in pediatrics, despite a decline in overall revenue.